[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100246583":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":11,"locations":19,"responsibleParty":33,"collaborators":35,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":41,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":11,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":61,"whyStopped":11,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"Gustave Roussy, Cancer Campus, Grand Paris","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with non-Hodgkin's lymphoma","EXPERIMENTAL",null,[13],"Device: PET \u002F CT",[15],{"type":16,"name":17,"description":11,"armGroupLabels":18,"otherNames":11},"DEVICE","PET \u002F CT",[9],[20],{"facility":21,"status":11,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":11},"Gustave Roussy Cancer Campus Grand Paris","Villejuif","Val De Marne","94805","France","FR",{"type":28,"coordinates":29},"Point",[30,31],2.35992,48.7939,{"lat":31,"lon":30},{"type":34,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[36],{"name":37,"class":38},"Société Française des Cancers et Leucémies de l'Enfant et de l'Adolescent (SFCE)","UNKNOWN","100246583","diagnostic-qualities-of-the-positron-emission-tomography-coupled-to-the-scanner-pet--ct-in-the-assessment-of-response-to-non-hodgkins-lymphoma-therapy-in-children-and-adolescents-100246583",false,"NCT02488369","Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET \u002F CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents","Study on the Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET \u002F CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents","TEP-LYMPHOME","Inclusion Criteria:\n\n1. All cases of NHL corresponding to one of the following histologies:\n\n   * Burkitt and Burkitt-like (LB)\n   * Large cell B-cell lymphoma (LBGC)\n   * Primary mediastinal B cell lymphoma (LBPM)\n   * Lymphoblastic lymphoma (LL)\n   * Anaplastic large cell lymphoma (ALCL)\n2. Age \\> 2 years and \\\u003C 21 years\n3. Treated in a SFCE protocol\n4. Treated in a center with the possibility of organizing a PET \u002F CT at the time of remission assessment\n5. Affiliation to a social security system\n6. Possible follow-up for at least 2 years\n7. written informed consent signed by the parents or parental authority or the patient himself if he is over 18 years\n\nExclusion Criteria:\n\n1. relapsing patients\n2. Patients with absolute cons-indications to the achievement of a PET scan: pregnancy, incontinence, poorly controlled diabetes or blood glucose\\> 10 mmol\u002Fl, alterations of superior functions or claustrophobia, making the test impossible.\n3. pre-existing or evolving infectious inflammatory disease making PET \u002F CT difficult to interpret","ALL","2 Years","21 Years",{"count":51,"type":52},230,"ACTUAL","INTERVENTIONAL",[55],"NA","This is a diagnostic prospective multicenter study. This study will be conducted in 32 centers of the Société Française des Cancers et Leucémies de l'Enfants et de l'Adolescent (SCFE) in patients with non-Hodgkin lymphoma and treated according to recommendations of the SFCE for each type of non-Hodgkin lymphoma. All patients will have a PET \u002F CT associated with conventional imaging time of remission assessment. Histological examination of residual tumor will be conducted whenever practicable in patients with pathologic residual image on conventional imaging and \u002F or PET \u002F CT. A central review of conventional imaging examinations and PET \u002F CT will be performed independently from each other.\n\nMoreover, whenever possible, patients will have a PET \u002F CT at diagnosis and an early PET \u002F CT (between J8 and J28 according to the type of lymphoma and toxicities due to treatment). The results of the early PET \u002F CT should not lead to treatment modifications.\n\nIn case of residual tumor at remission assessment, therapeutics changes as recommended therapeutic protocols will be based on histologic findings and not on the results of PET \u002F CT alone.",[58],"Non-Hodgkin Lymphoma",[60],"Children and adolescents","COMPLETED","2019-06-14",{"date":64,"type":52},"2019-06-18",{"date":66,"type":52},"2011-03-31",{"date":68,"type":52},"2018-01-25",{"name":5,"class":6},1]